Skip to main content
OpenTrials
Completed

NCT Number: NCT03266757

Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma

Observational study of the Clinical Practice in patients with Borderline resectable or resectable or advanced pancreatic adenocarcinoma.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pancreatic Adenocarcinoma

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients Age 18 or older with histologically confirmed ductal pancreatic adenocarcinoma as a primary tumor
  • Patients with ductal pancreatic adenocarcinoma (Borderline resectable or resectable or advanced)
  • Patients that are alive and under treatment or follow up
  • Signed informed consent (ICF)

Exclusion criteria

  • Presence of other primary tumors
  • Pancreatic adenocarcinoma due to metastasis from other primary tumor(s)
  • Neuroendocrine or other pancreatic carcinoma other than ductal adenocarcinoma
  • Patients who refuse to provide informed consent

Treatment and study plan

Primary outcomes

  1. clinical practice-treatments

    Time frame: 2 years

Secondary outcomes

  1. progression Free Survival

    Time frame: 2 years

  2. Overall Survival

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Hellenic Society of Medical Oncology

Other

Registry information

Official study title

Observational Study of the Clinical Practice in Patients With Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma in Greece

Important dates

Study start
2016
Primary completion
2017
Study completion
2018
First posted
Aug 30, 2017
Registry last updated
Apr 5, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.